There is no doubt that many of the physical side effects of steroid misuse and abuse can contribute to emotional and mental side effects and disorders.
Before & After Pictures Gained 25 LB lean muscle ★ ★ ★ ★ ★ Gaining 13lbs in 4 weeks and staying lean while still getting stronger was something I’ve not done before! Cole W. VIEW REVIEW Lost 20 LB fat & gained muscle ★ ★ ★ ★ ★ I went from 260lbs to 240lbs. My strength definitely increased all around and was able to workout harder and longer. Joey B. VIEW REVIEW Gained 20 LB lean muscle ★ ★ ★ ☆ ☆ Its been a month since I started and I have gained 20 pounds and also went up in strength between 30-60 pounds. James P. VIEW REVIEW Lost 17 lbs of body fat ★ ★ ★ ★ ★ The stack helped me achieve everything I’ve always wanted. I started to lose weigh in my stomach; my waist line declined for 5 cm. William F.
Dangers of Injecting Steroids It’s not just physical and emotional/mental side effects that steroid users have to worry about.
American Medical Association, Council on Scientific Affairs. Medical and non-medical uses of anabolic-androgenic steroids. J. Amer. Med. Assoc. 264: 2923-2927, 1990.
Bahrke, ., . Yesalosk, and . Wright. Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males: a review. Sports Med. 10: 303-337, 1990.
Buckley, ., . Yasalis, . Friedl, . Anderson, . Streit, and . Wright. Estimated prevalance of anabolic steroid use among male high school seniors. J. Amer. Med. Assoc. 260: 3441-3445, 1988.
Rogozkin, V. Metabolism of Anabolic Androgenic Steroids. Leningrad: Nauka, 1988.
United States Olympic Committee. USOC Drug Education Handbook. Colorado Springs: USOC, 1989.
Assessment of Aggressive Behavior and Plasma Testosterone in a Young Criminal PopulationLeo E. Kreuz, MD, MAJ, MCand Robert M. Rose, MD, June 23, 1971. Revision received December 1, 1971. 1972 American Psychosomatic Society
BEHRE, ., K. ABSHAGEN, M. OETTEL, D. HUBLER AND E. NIESCHLAG. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. Eur J Endocrinol 140:414 ***8211; 419. 1999